Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease:a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

Subjects

Subjects :

safety
medicine.medical_specialty
medicine.medical_treatment
Cardiology
Myocardial Infarction
Alternative medicine
MEDLINE
Disease
030204 cardiovascular system & hematology
outcomes
Incretins
Glucagon-Like Peptide-1 Receptor
drugs
NO
03 medical and health sciences
0302 clinical medicine
Pharmacotherapy
et-al
prevention
Internal medicine
Diabetes mellitus
inhibitors
medicine
Journal Article
Humans
Hypoglycemic Agents
Glycoside Hydrolase Inhibitors
In patient
030212 general & internal medicine
Sodium-Glucose Transporter 2 Inhibitors
Societies, Medical
risk
Glycated Hemoglobin
Dipeptidyl-Peptidase IV Inhibitors
Diabetes-mellitus
business.industry
heart-failure
Insulin
medicine.disease
Metformin
Europe
Stroke
events
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Position paper
Cardiology and Cardiovascular Medicine
business

Details

Language :

English

ISSN :

15229645

Database :

OpenAIRE

Journal :

Niessner, A, Tamargo, J, Koller, L, Saely, C H, Schmidt, T A, Savarese, G, Wassmann, S, Rosano, G, Ceconi, C, Torp-Pedersen, C, Kaski, J C, Kjeldsen, K P, Agewall, S, Walther, T, Drexel, H & Lewis, B S 2018, ' Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease : a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal, vol. 39, no. 24, pp. 2274–2281 . https://doi.org/10.1093/eurheartj/ehx625

Accession number :

edsair.doi.dedup.....ca6978b28efa9bdbe5e5092aefe32c43

Full Text :

https://doi.org/10.1093/eurheartj/ehx625